美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco S&P 500 Equal Weight Health Care ETF

37.47

+0.07000.19%

盤前：37.470.00000.00%08:10 EDT

成交量：58.61萬

成交額：2,197.42萬

市值：8.34億

市盈率：- -

高：37.86

開：37.60

低：37.42

收：37.40

52周最高：38.19

52周最低：28.26

股本：2,225.00萬

流通股本：2,225.00萬

量比：4.12

換手率：2.63%

股息：0.23

股息率：0.62%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

深入挖掘創新項目深圳市市場監督管理局組織開展2026年醫療器械重點創新項目路演遴選活動

深圳新闻网

九強生物：取得葉酸測定試劑盒醫療器械註冊證

新華醫療(600587.SH)產品獲得三類和二類醫療器械註冊證

新華醫療：獲得三類及二類醫療器械註冊證

國金證券：雙輪驅動醫療器械內外復甦聚焦創新與出海主線

港股異動 | 今海醫療科技(02225)升逾5% 上半年收益按年大幅增超1.3倍戰略重心轉向高附加值醫療器械賽道

美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極

透景生命(300642.SZ)取得醫療器械註冊證

醫療器械迎業績拐點？512170成功收紅！AI4S帶火港股CXO，金斯瑞升逾7%！港股通醫療ETF華寶逆市上揚

賽諾醫療：子公司輸送型球囊擴張導管獲醫療器械註冊證

東方海洋(002086.SZ)：清道夫受體-A(SR-A)測定試劑盒獲得醫療器械註冊證

美年健康在寧波投資成立數智科技公司

步步高等成立商貿公司

Hims & Hers在澳大利亞推出GLP-1減肥藥及治療方案

美國醫療保險和醫療補助服務中心：將為阿肯色州農村醫院提供資金，用於升級救護車、拓展遠程醫療服務並安裝應急發電機

機構：爭奪天然氣資產推高併購交易規模創2013年以來新高

不止步於「減肥藥之王」禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道

不止步於「減肥藥之王」禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道

透景生命(300642.SZ)子公司取得醫療器械註冊證

凱普生物(300639.SZ)子公司取得醫療器械註冊證書

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/RSPH/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":37.47,"timestamp":1788292800000,"preClose":37.4,"halted":0,"volume":586069,"hourTrading":{"tag":"盘前","latestPrice":37.47,"preClose":37.47,"latestTime":"08:10 EDT","volume":1,"amount":37.47,"timestamp":1788351018300,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.001871657754010703,"floatShares":22250000,"shares":22250000,"eps":0,"marketStatus":"盤前交易","change":0.07,"latestTime":"09-02 08:56:00 EDT","open":37.6,"high":37.86,"low":37.42,"amount":21974242.804217,"amplitude":0.011765,"askPrice":41.03,"askSize":100,"bidPrice":33.6,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":37.47,"sharesOutstanding":23410000,"nav":37.40491,"aum":837121885.8,"dividendRate":0.006194,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":37.47,"preClose":37.47,"latestTime":"08:10 EDT","volume":1,"amount":37.47,"timestamp":1788351018300,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.47,"preClose":37.47,"latestTime":"19:48 EDT","volume":19,"amount":712.74,"timestamp":1788306513984,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":4.120410076410875,"impliedVol":0.3468,"impliedVolPercentile":0.9841},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":22250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.120410076410875,"shares":22250000,"dividePrice":0.2321,"high":37.86,"amplitude":0.011765,"preClose":37.4,"low":37.42,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":37.47,"eps":0,"divideRate":0.006194,"volume":586069,"delay":0,"ttmEps":0,"open":37.6,"prevYearClose":31.85,"prevWeekClose":37.44,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":38.02,"twentyDayClose":35.21,"sixtyDayClose":31.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"RSPH","amount":0.05546,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.198297,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664811819","title":"深入挖掘創新項目 深圳市市場監督管理局組織開展2026年醫療器械重點創新項目路演遴選活動","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811819","media":"深圳新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811819?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:25","pubTimestamp":1788348300,"startTime":"0","endTime":"0","summary":"深圳市市场监督管理局已连续两年开展医疗器械重点创新项目路演遴选活动。2026年深圳市市场监督管理局将延续去年经验做法，为遴选出的项目提供快速链接服务，助力项目加快注册审批、实现成果转化。下一步，深圳市市场监督管理局将根据本次路演遴选结果，向国家药监局、省药监局及产业部门精准推荐重点服务项目。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-02/doc-iniqmwqu2753585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1583","PTH","RSPH","LNGR","159883","MDEV","GDOC","HART","AGNG","MEDX","09996","LGHT","BK1574","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894050","title":"九強生物：取得葉酸測定試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894050","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894050?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:54","pubTimestamp":1788335696,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","MEDX","LGHT","IEIH","HART","PTH","MDEV","AGNG","RSPH","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664489420","title":"新華醫療(600587.SH)產品獲得三類和二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664489420","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664489420?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:44","pubTimestamp":1788335097,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华医疗 发布公告，公司近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》、子公司新华手术器械有限公司于近日收到山东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》。该产品取得注册证后，不仅丰富了公司在微创腔镜领域的产品矩阵，也提升了在胸腔镜手术领域的综合竞争力，有助于扩大市场覆盖范围并增强品牌影响力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","HART","BK0028","600587","BK0251","LNGR","09996","RSPH","LGHT","BK1100","GDOC","MEDX","BK1583","BK0188","IEIH","PTH","MDEV","BK1574","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664489426","title":"新華醫療：獲得三類及二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664489426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664489426?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:44","pubTimestamp":1788335042,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","RSPH","PTH","LNGR","MDEV","HART","GDOC","LGHT","IEIH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894673","title":"國金證券：雙輪驅動醫療器械內外復甦 聚焦創新與出海主線","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894673","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894673?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:25","pubTimestamp":1788333958,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国金证券发布研报称，医疗器械板块当前投资应紧扣“出海拓增量、创新守利润”的双轮驱动逻辑，同时把握国内需求复苏节奏。出海能有效分散集采风险，打开成长天花板，而持续的高强度研发投入则是维持高毛利率、抵御价格战的关键护城河。国金证券主要观点如下：医疗设备收入端同比稳定增长，毛利率略有承压。医疗耗材收入增速快速恢复，毛利率显著提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","159883","09996","RSPH","BK0276","600109","BK1574","PTH","IEIH","BK1100","LGHT","MEDX","BK0188","HART","BK0012","GDOC","BK0201","LNGR","MDEV","BK0028","AGNG","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899822","title":"港股異動 | 今海醫療科技(02225)升逾5% 上半年收益按年大幅增超1.3倍 戰略重心轉向高附加值醫療器械賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899822","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664899822?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 14:04","pubTimestamp":1788329049,"startTime":"0","endTime":"0","summary":"消息面上，近期，今海医疗科技披露2026年中期业绩。2026年上半年，集团实现收益3402.1万新加坡元，同比大幅增长134.16%，展现出强劲的销售增长动能。业务端，2026年上半年，公司收入结构显著优化，战略重心已成功从传统劳务服务转向高附加值的医疗器械赛道。继2025年医疗器械销售收益实现良好增长后，2026年上半年该业务收益同比激增301.5%，达到2542.7万新加坡元，可持续增长动力充足。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","RSPH","GDOC","BK1583","KCAI","MEDX","02225","HART","LGHT","09996","BK1100","IEIH","BK4585","VXUS","PTH","BK1150","AGNG","159883","MDEV","LNGR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664521258","title":"美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2664521258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664521258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:18","pubTimestamp":1788272338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["WDNA","CANC","FBT","AZNH","BME","IE00B4R5TH58.HKD","MEDI","BIOY","NVS","BBH","XPH","IBRN","LU2272731600.USD","PJP","TMED","IEHS","LU0070302665.USD","BK4585","LFSC","FTXH","BBP","MEDX","MRNY","GNOM","RXL","SBIO","PBPH","IE00BJT1NW94.SGD","RSPH","IE00BFTCPJ56.SGD","PSCH","IE0002141913.USD","LU2473716301.USD","IYH","LU0211331839.USD","BIB","SYNB","LU2322448957.HKD","IDNA","XBIX","IE0009355771.USD","IBB","PPH","BK4588","BK4007","PBE","IE00BJJMRZ35.SGD","MRNX","IEIH","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855470","title":"透景生命(300642.SZ)取得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855470","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855470?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:34","pubTimestamp":1788262475,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司及控股子公司上海脉示生物技术有限公司于近日取得上海市药品监督管理局颁发的6项医疗器械注册证。上述医疗器械注册证的取得，丰富了公司及子公司在多个技术平台的产品线布局，进一步完善公司在非肿瘤检测领域的业务布局，有利于提升公司整体品牌影响力和市场拓展能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","MEDX","LNGR","GDOC","LGHT","AGNG","PTH","IEIH","BK0046","BK0042","HART","09996","300642","BK0239","BK1100","RSPH","BK1574","MDEV","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855519","title":"醫療器械迎業績拐點？512170成功收紅！AI4S帶火港股CXO，金斯瑞升逾7%！港股通醫療ETF華寶逆市上揚","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855519","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855519?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:12","pubTimestamp":1788261120,"startTime":"0","endTime":"0","summary":"9月1日，A股港股医疗板块逆市表现，医疗ETF华宝、港股通医疗ETF华宝等相关品种热度再升温。医疗器械方面，英科医疗上半年营收、净利双增，迈瑞医疗利润降幅显著收窄至5.4%，联影医疗营收同比增长17%。中信建投研报指出，医疗器械行业迎来业绩修复拐点，2026Q2归母净利润实现四年首正增长，板块整体企稳回升。聚焦医疗器械+医疗服务，CXO含量超30%，兼顾脑机接口、AI医疗。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-01/doc-iniqipis4811448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HART","BK1574","MEDX","BK1583","PTH","512170","159883","GDOC","09996","LGHT","CXO","MDEV","WX","BK4588","IEIH","AGNG","VXUS","BK1100","LNGR","RSPH","KCAI","BK4585","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664858778","title":"賽諾醫療：子公司輸送型球囊擴張導管獲醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664858778","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664858778?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:35","pubTimestamp":1788258920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","HART","RSPH","AGNG","MDEV","LGHT","MEDX","GDOC","IEIH","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831017","title":"東方海洋(002086.SZ)：清道夫受體-A(SR-A)測定試劑盒獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831017","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831017?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 16:03","pubTimestamp":1788249802,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方海洋(002086.SZ)发布公告，公司全资子公司艾维可生物科技有限公司自主研发的清道夫受体-A(SR-A)测定试剂盒(磁微粒化学发光法)于近日取得了山东省药品监督管理局的注册批准，获得医疗器械注册证。该产品用于体外定性测定人体血清、血浆中的清道夫受体-A(SR-A)。上述产品获准上市，进一步丰富了艾维可生物科技有限公司在临床检测领域的产品线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IEIH","LGHT","BK1574","MDEV","MEDX","09996","159883","BK1100","HART","LNGR","002086","BK1583","BK0046","PTH","AGNG","BK0213","BK0092","GDOC","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831126","title":"美年健康在寧波投資成立數智科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831126","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831126?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:50","pubTimestamp":1788249053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","RSPH","GDOC","PTH","LNGR","IEIH","MDEV","LGHT","HART","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880657","title":"步步高等成立商貿公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880657","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664880657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 11:46","pubTimestamp":1788234379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","MEDX","RSPH","MDEV","LGHT","LNGR","AGNG","IEIH","HART","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882140","title":"Hims & Hers在澳大利亞推出GLP-1減肥藥及治療方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882140","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882140?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 10:10","pubTimestamp":1788228656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LLYX","RSPH","NVOC","FHLC","IYH","ELIL","PINK","ELIS","THNR","JDOC","CURE","NVOH","OZEM","XLVI","FXH","LLII","MEDI","NVOX","PJP","TRUH","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008470","title":"美國醫療保險和醫療補助服務中心：將為阿肯色州農村醫院提供資金，用於升級救護車、拓展遠程醫療服務並安裝應急發電機","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008470","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664008470?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 02:18","pubTimestamp":1788200331,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HEAL","LU0390134368.USD","LU0211331839.USD","BK4588","UNHW","IEHS","LU0070302665.USD","FXH","LU1983260115.SGD","SG9999014005.SGD","LU0320765489.SGD","LU0266013472.USD","UN","IHF","LU0238689110.USD","GDOC","LU1093756325.SGD","UNHU","BK4566","LGHT","LU1093756168.USD","IEIH","LU0417517546.SGD","BK4533","BK4585","HUM","SG9999014013.SGD","EKG","RSPH","BK4154","LU0256863811.USD","SG9999014021.USD","UNHG","FDHT","LU0170899867.USD","BMED","LU0208291251.USD","LU0348723411.USD","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017770","title":"機構：爭奪天然氣資產推高併購交易規模創2013年以來新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017770","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017770?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 22:52","pubTimestamp":1788187964,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WTIU","CANC","IBBQ","FTXN","RSPH","PXE","DBC","DUG","BK4585","DRLL","IEFN","IYH","XES","XOP","PRVT","IXC","ACTV","PXJ","DFMC","UYG","USE","MMID","AAUM","TBXU","DBE","IEO","PSP","FCG","VDE","BK4588","FFSM","GUSH","RFG","VXF","BK4570","GTPE","DRIP","KOLD","PBPH","PEVC","XLFI","DIG","TMED","MNA","ERX","BOIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006809","title":"不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006809","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006809?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来计划以高达28.8亿美元的现金收购Merida Biosciences Inc.，加码自身免疫与过敏疾病领域，以摆脱对减重和糖尿病两大支柱业务的过度依赖——正是这两大市场助其登顶全球药企市值之巅。今年以来，礼来掀起并购狂潮，迄今已宣布的交易总额超过200亿美元。5月，礼来还达成协议，以最高38亿美元收购三家疫苗研发企业。截至发稿，礼来盘前跌0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLVI","FHLC","NVOC","THNR","CURE","FXH","NVOX","PINK","PJP","NBDS","MEDI","IYH","NVOH","RSPH","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006800","title":"不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006800?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XLVI","FXH","MEDI","NVOH","PJP","CURE","NVOC","IYH","TRUH","FHLC","PINK","NBDS","RSPH","THNR","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074020","title":"透景生命(300642.SZ)子公司取得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074020","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074020?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:34","pubTimestamp":1788172480,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司控股子公司河北透景生命科技有限公司于近日取得国家药品监督管理局颁发的1项医疗器械注册证，产品为曲霉半乳甘露聚糖检测试剂盒(磁微粒化学发光法)。该产品可用于体外定性检测人血清或肺泡灌洗液样本中的曲霉半乳甘露聚糖，其检测结果用于曲霉感染的辅助诊断。此次医疗器械注册证的取得，将进一步增强公司及子公司在真菌检测领域的综合竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LNGR","BK0239","BK0042","09996","BK1574","BK1100","300642","BK1583","IEIH","RSPH","MDEV","PTH","LGHT","AGNG","HART","MEDX","BK0046","159883","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075807","title":"凱普生物(300639.SZ)子公司取得醫療器械註冊證書","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075807","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663075807?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 16:36","pubTimestamp":1788165374,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)发布公告，近日，公司的全资子公司潮州凯普生物化学有限公司(简称“凯普化学”)取得国家药品监督管理局颁发的《中华人民共和国医疗器械注册证(体外诊断试剂)》，产品名称：基孔肯雅病毒/登革病毒核酸检测试剂盒(荧光PCR法)，该产品用于体外定性检测人血清或血浆样本中的基孔肯雅病毒和登革病毒的核酸。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PTH","BK0046","RSPH","09996","300639","LGHT","BK1574","LNGR","BK1583","MEDX","GDOC","HART","IEIH","BK0132","AGNG","159883","MDEV","BK1100","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":181,"code":"91000000","status":"200"}]}}